GDERF — Galderma Group AG/ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 2021390 ·
Last close
$212.05
Market Cap
$49.74B
52W High
$248.46
52W Low
$172.75
ADV30
577
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 13,393,000,000 | 780,000,000 | 5,244,000,000 |
| Jun 2025 | — | — | — | — | 12,877,000,000 | 458,000,000 | 5,147,000,000 |
| Dec 2024 | — | — | — | — | 12,617,000,000 | 457,000,000 | 4,827,000,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$6,347,000,000
Inventory
$525,000,000
Receivables
—
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,240,999,936
EBITDA
$1,134,000,000
Free Cash Flow
$905,000,000
Enterprise Value
$51,714,297,856
Total Cash
$780,000,000
Total Debt
$2,753,999,872
Shares Out
234,568,725
Trailing EPS
$2.59
Book Value
$34.74
ROE
7.7%
ROA
4.3%
Div Yield
0.21%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,241,000,000 | 876,000,000 | 613,000,000 | 13,393,000,000 | 5,244,000,000 | — | 1,185,000,000 |
| Dec 2024 | 4,440,000,000 | 678,000,000 | 231,000,000 | 12,617,000,000 | 4,827,000,000 | — | 488,000,000 |
| Dec 2023 | 4,117,000,000 | 611,000,000 | -57,000,000 | 12,471,000,000 | 7,102,000,000 | — | 165,000,000 |
| Dec 2022 | 3,823,900,000 | 406,000,000 | -98,500,000 | — | — | — | 111,300,000 |
News headlines (Yahoo Finance, 1h cache)
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
2026-05-22 16:25 · Yahoo
What Makes Galderma Group AG - Unsponsored ADR (GALDY) a New Strong Buy Stock
2026-05-05 16:00 · Yahoo
European Market Insights 3 Stocks Estimated Below Fair Value
2026-04-29 10:37 · Yahoo
3 European Stocks Estimated To Be Up To 48.1% Below Intrinsic Value
2026-04-29 05:38 · Yahoo
Galderma Reports Strong Start to the Year, Delivering First Quarter 2026 Net Sales of 1.473 Billion USD, Growing 25.5% at Constant Currency
2026-04-23 05:00 · Yahoo
Galderma Shareholders Approve All Annual General Meeting Proposals
2026-04-22 15:45 · Yahoo
Assessing Galderma Group (SWX:GALD) Valuation After Recent Share Price Resilience
2026-03-26 18:07 · Yahoo
Galderma Publishes Invitation and Agenda for Its 2026 Annual General Meeting
2026-03-20 05:55 · Yahoo
EQT exits Galderma Group AG in full via largest sponsor-backed block trade ever
2026-03-13 18:17 · Yahoo
Galderma Buys Back Shares Worth CHF 232 Million in the Context of Accelerated Bookbuild Offering
2026-03-11 06:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.